CAM
CBST

Cormorant Asset Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Cormorant Asset Management’s Portfolio CBST Stock Details CBST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-300,000
Closed -$21.9M – 62
2014
Q1 		$21.9M Sell
300,000
-100,000
-25% -$7.46M 5.05% 2
2013
Q4 		$27.5M Buy
+400,000
New +$25.9M 7.99% 2

Other funds holding CBST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Cormorant Asset Management's CBST Position: Q2 2014 in Review

Cormorant Asset Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q2 2014, closing a stake of 300,000 shares — an estimated $21.9M sold.

Cormorant Asset Management first reported a position in CBST in Q4 2013 and held it in 2 quarters. The position peaked at $27.5M in Q4 2013. 270 funds tracked by Wall St. Rank hold CBST as of Q2 2014.

  • Cormorant Asset Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q2 2014 after selling out during the quarter.
  • Cormorant Asset Management sold 300,000 CUBIST PHARMACEUTICALS INC shares in Q2 2014, an estimated $21.9M.
  • Cormorant Asset Management first reported a position in CUBIST PHARMACEUTICALS INC in Q4 2013 and held it in 2 quarters.
  • Cormorant Asset Management's CUBIST PHARMACEUTICALS INC position peaked at $27.5M in Q4 2013.
  • 270 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q2 2014.

Based on Cormorant Asset Management's 13F filing for Q2 2014, filed 14 Aug 2014.